Recro Pharma, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, signed a master supply and services agreement with Otsuka Pharmaceutical Co., Ltd. Under terms of the agreement, Recro will serve as a commercial manufacturing and supplier for Otsuka.   “The opportunity to support Otsuka’s supply chain risk management efforts while serving as their U.S.-based s...